Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells (original) (raw)
References
Azzam H, Arrand GA, Lippman ME and Thompson EW, 1993, MMP-2 activation potential associates with metastatic progression in human breast cancer cell lines, and is independent of MMP-2 production. JNCI, 85, 1758–64. Google Scholar
Gilles C, Polette M, Piette J, Birembaut P and Foidart JM, 1994, Epithelial to mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A. Int J Cancer, 59, 661–6. Google Scholar
Brown PD, Levy AT, Margulies IM, Liotta LA and Stetler-Stevenson WG, 1990, Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res, 50, 6184–91. Google Scholar
Ward RV, Atkinon SJ, Slocombe PM _et al._1991, Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membrane. Biochem Biophys Acta, 1079, 242–6. Google Scholar
Murphy G, Willenbrock F, Ward RV _et al._1992, The C-terminal domain of the 72 kDa gelatinase A is not required for catalysis but is essential for membrane activation and modulates interactions with tissue inhibitor of metalloproteinases. Biochem J, 283, 637–41. Google Scholar
Overall CM and Sodek J, 1990, Concanavalin A produces a matrix-degradive phenotype in human fibroblasts. J Biol Chem, 265, 21141–51. Google Scholar
Sato H, Takino T, Okada, _et al._1994, A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature, 370, 61–5. Google Scholar
Gilles C, Polette M, Piette J, _et al._1996, High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer, 65, 209–13. Google Scholar
Yu M, Sato H, Seiki M and Thompson EW, 1995, Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin in MDA-MB-231 human breast cancer cells. Cancer Res, 55, 3272–7. Google Scholar
Yamamoto M, Mahanam S, Sawaya R, et al. 1996, Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors _in vivo_and in vitro. Cancer Res, 56, 384–92. Google Scholar
MacDougall JR and Matrisian LM, 1995, Contributions of tumor stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev, 14, 351–62. Google Scholar
Polette M and Birembaut P, 1996,Metalloproteinases and breast carcinomas. Breast J, 2, 1–13. Google Scholar
Birkedal-Hansen H, Moore WGI, Bodden MK, _et al._1993, Matrix metalloproteinases: A review. Crit Rev Oral Biol Med, 4, 197–250. Google Scholar
Ellis SM, Nabeshima K and Biswas C, 1989, Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor. Cancer Res, 49, 3385–91. Google Scholar
Kataoka H, Decastro R, Zucker S and Biswas C, 1993, Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin and 72-kDa gelatinase. Cancer Res, 53, 3154–8. Google Scholar
Thompson EW, Paik S, Brünner N, _et al._1992, Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol, 150, 534–44. Google Scholar
Seog-Nyeon B, Arand G, Azzam H, et al. 1993, Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigelbased _in vitro_assays. Breast Cancer Res Treat, 24, 214–55. Google Scholar
Okada A, Bellocq JP, Rouyer N, _et al._1995, Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA, 92, 2730–4. Google Scholar
Polette M, Nawrocki B, Gilles C, _et al._1996, MT-MMP expression and localisation in human breast and lung cancers. Virchows Arch, 428, 29–35. Google Scholar
Himelstein BP, Canete-Soler R, Bernhard E and Muschel RJ, 1992, Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci, 107, 477–86. Google Scholar
Noël AC, Munaut C, Nusgens B, Lapiere CM and Foidart JM, 1993, Different mechanisms of extracellular matrix remodelling by fibroblasts in reponse to human mammary neoplastic cells. Inv Metastasis, 13, 72–81. Google Scholar
Noël AC, Polette M, Lewalle JM, _et al._1994, Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cell. Int J Cancer, 56, 331–6. Google Scholar
Gilles C and Thompson EW, 1996, The epithelial to mesenchymal transition and metastatic progression in carcinoma. Breast J, 2, 83–96. Google Scholar
Ito A, Nakajima S, Sasaguri Y, Nagase H and Mori Y, 1995, Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer, 71, 1039–45. Google Scholar
Miyagi E, Yasumitsu H, Hirahara F, _et al._1995, Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice. Clin Exp Metastasis, 13, 89–96. Google Scholar
Bates SE, Davidson NE, Valverius EM, _et al._1988, Expression of transforming growth factor a and its messenger ribonucleic acid in human breast cancer: its regulation by oestrogen and its possible functional significance. Mol Endocrinol, 2, 543–55. Google Scholar
Luparello C, Ginty AF, Gallagher JA, Pucci-Minafra I and Minafra S, 1993, Transforming growth factorβ1, β2, and β3, urokinase and parathyroid hormonerelated peptide expression in 8701-BC breast cancer cells and clones. Different, 55, 73–80. Google Scholar
Unemori EN, Hibbs MS and Amento EP, 1991, Constitutive expression of 92-kDa gelatinase (type IV) collagenase by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest, 88, 1656–62. Google Scholar
Pei D and Weiss SJ, 1996, Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process proMMP-2 and express intrinsic matrix-degrading activity. J Biol Chem, 271, 9135–40. Google Scholar